Skip to main content
. 2022 Apr;16(4):E184–E196. doi: 10.5489/cuaj.7851

Fig. 1.

Fig. 1

Prostate cancer screening pathway. aDiscontinue screening if life expectancy <10 years; bconsider discontinuation of screening if age >60 and PSA <1 ng/ml; cmore frequent testing interval can be considered; the optimal frequency is unknown; di.e., risk calculators, % free PSA, etc. PSA: prostate-specific antigen.